162 related articles for article (PubMed ID: 18347171)
1. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
[TBL] [Abstract][Full Text] [Related]
2. Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities.
Kikuta K; Gotoh M; Kanda T; Tochigi N; Shimoda T; Hasegawa T; Katai H; Shimada Y; Suehara Y; Kawai A; Hirohashi S; Kondo T
Jpn J Clin Oncol; 2010 Jan; 40(1):60-72. PubMed ID: 19815537
[TBL] [Abstract][Full Text] [Related]
3. Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities.
Kubota D; Orita H; Yoshida A; Gotoh M; Kanda T; Tsuda H; Hasegawa T; Katai H; Shimada Y; Kaneko K; Kawai A; Kondo T
Jpn J Clin Oncol; 2011 Oct; 41(10):1194-202. PubMed ID: 21903705
[TBL] [Abstract][Full Text] [Related]
4. Distinct gene expression-defined classes of gastrointestinal stromal tumor.
Yamaguchi U; Nakayama R; Honda K; Ichikawa H; Hasegawa T; Shitashige M; Ono M; Shoji A; Sakuma T; Kuwabara H; Shimada Y; Sasako M; Shimoda T; Kawai A; Hirohashi S; Yamada T
J Clin Oncol; 2008 Sep; 26(25):4100-8. PubMed ID: 18757323
[TBL] [Abstract][Full Text] [Related]
5. Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour.
Kubota D; Okubo T; Saito T; Suehara Y; Yoshida A; Kikuta K; Tsuda H; Katai H; Shimada Y; Kaneko K; Kawai A; Kondo T
Jpn J Clin Oncol; 2012 Aug; 42(8):730-41. PubMed ID: 22723667
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibody.
Kubota D; Mukaihara K; Yoshida A; Suehara Y; Saito T; Okubo T; Gotoh M; Orita H; Tsuda H; Kaneko K; Kawai A; Kondo T; Sato K; Yao T
Jpn J Clin Oncol; 2013 Jun; 43(6):669-75. PubMed ID: 23619989
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.
Li CF; Huang WW; Wu JM; Yu SC; Hu TH; Uen YH; Tian YF; Lin CN; Lu D; Fang FM; Huang HY
Clin Cancer Res; 2008 Dec; 14(23):7822-31. PubMed ID: 19047110
[TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
[TBL] [Abstract][Full Text] [Related]
11. [Biomarker development by cancer proteomics].
Kondo T
Nihon Rinsho; 2012 May; 70(5):754-8. PubMed ID: 22619997
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
14. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
Sabah M; Cummins R; Leader M; Kay E
Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
[TBL] [Abstract][Full Text] [Related]
16. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
17. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
19. Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors.
Kamo N; Naomoto Y; Shirakawa Y; Yamatsuji T; Hirota S; Fujiwara Y; Noma K; Sakurama K; Takaoka M; Nagatsuka H; Gunduz M; Matsuoka J; Tanaka N
Hum Pathol; 2009 Nov; 40(11):1643-9. PubMed ID: 19695682
[TBL] [Abstract][Full Text] [Related]
20. Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation.
Hirano K; Shishido-Hara Y; Kitazawa A; Kojima K; Sumiishi A; Umino M; Kikuchi F; Sakamoto A; Fujioka Y; Kamma H
Pathol Res Pract; 2008; 204(11):799-807. PubMed ID: 18602222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
